Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_4
1
25%
Ph phase_2
1
25%
Ph phase_1
2
50%

Phase Distribution

2

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
Phase 2Efficacy & side effects
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Active(3)
Other(1)

Detailed Status

Not yet recruiting3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 12 (50.0%)
Phase 21 (25.0%)
Phase 41 (25.0%)

Trials by Status

unknown125%
not_yet_recruiting375%

Recent Activity

0 active trials
Showing 4 of 4
not_yet_recruitingphase_1

[Effects of Selected Statins on Cardiovascular Parameters in Healthy Volunteers]

NCT07389304
not_yet_recruitingphase_1

Effects of Selected Statins on Blood Glucose Levels in Healthy Volunteers

NCT07378293
not_yet_recruitingphase_2

Investigating Measurable PRO Acuity Trial (IMPACT) is a Multi-Center Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Maraviroc and Atorvastatin to Improve Neurocognitive and Physical Function of Subjects With Long COVID-19/Post-Acute Sequelae of COVID-19 (PASC).

NCT06974084
unknownphase_4

Korean AMADEUS Study

NCT01239849

Clinical Trials (4)

Showing 4 of 4 trials
NCT07389304Phase 1

[Effects of Selected Statins on Cardiovascular Parameters in Healthy Volunteers]

Not Yet Recruiting
NCT07378293Phase 1

Effects of Selected Statins on Blood Glucose Levels in Healthy Volunteers

Not Yet Recruiting
NCT06974084Phase 2

Investigating Measurable PRO Acuity Trial (IMPACT) is a Multi-Center Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Maraviroc and Atorvastatin to Improve Neurocognitive and Physical Function of Subjects With Long COVID-19/Post-Acute Sequelae of COVID-19 (PASC).

Not Yet Recruiting
NCT01239849Phase 4

Korean AMADEUS Study

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4